Makoto Tada

Makoto Tada

Auto-generated profile, based on publicly available information

Makoto Tada

Department of Thoracic Surgery, Hakodate Goryoukaku Hospital, Hakodate, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2019 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
YTYuki Takahashi
Yuki Takahashi
MMMasahiro Miyajima
Masahiro Miyajima
MTMakoto Tada
Makoto Tada
RMRyunosuke Maki
Ryunosuke Maki
TMTaijiro Mishina
Taijiro Mishina
AWAtsushi Watanabe
Atsushi Watanabe
Completion lobectomy long after segmentectomy in the same lobe is extremely difficult because of severe adhesions around hilar structures, especially in cases involving video-assisted thoracoscopic surgery (VATS) completion lobectomy. We report and compare the surgical outcomes of patients who underwent VATS or thoracotomy completion lobectomy long after radical segmentectomy for lung cancer. We retrospectively evaluated the surgical outcomes of completion lobectomies performed at our institute long after radical segmentectomies for lung cancer in the same lobe. The efficacy and safety of VATS completion lobectomy was compared to that of thoracotomy completion lobectomy. Ten of 228 patients who underwent radical segmentectomy for lung cancer between 2009 and 2018 underwent completion lobectomy at least a month after segmentectomy; five patients underwent VATS completion lobectomy. None of the patients underwent VATS left upper completion lobectomy, and conversion to thoracotomy was required in one patient. There were no significant differences between VATS and thoracotomy completion lobectomies in the median operative times (VATS 295 min, thoracotomy 339 min, p = 0.55), intraoperative blood loss volumes (VATS 350 mL, thoracotomy 500 mL, p = 0.84), intervals between initial segmentectomy and completion lobectomy (VATS 40 months, thoracotomy 48 months, p = 0.55), and number of patients with pulmonary artery injury (VATS 1, thoracotomy 2, p = 0.49). There was no operation-related mortality. VATS completion lobectomy long after segmentectomy for lung cancer could be performed without fatal complications unless severe adhesions are observed around each main pulmonary artery.

1 September 2021 in Experimental Cell Research
Verified
Journal Article
Open access
YSYuji Sakuma
Yuji Sakuma
SHSachie Hirai
Sachie Hirai
TSToshiyuki Sumi
Toshiyuki Sumi
MTMakoto Tada
Makoto Tada
TKTakashi Kojima
Takashi Kojima
MYMiki Yamaguchi
Miki Yamaguchi
MCL1 is an anti-apoptotic BCL2 family member that is often overexpressed in various malignant tumors. However, few reports have described the role of MCL1 in squamous cell carcinoma (SqCC) derived from airways including the lung. In this study, we examined whether MCL1 could be a novel druggable target for airway-derived SqCC, for which effective molecular targeted drugs are unavailable. We searched the Kaplan-Meier Plotter database and found that high MCL1 mRNA expression was significantly associated with shorter survival in patients with lower airway (lung) or upper airway (head and neck) derived SqCC. We also explored the Expression Atlas database and learned that authentic lung SqCC cell lines expressing both TP63 and KRT5 mRNA were extremely sparse among the publicly available "lung SqCC cell lines", with an exception being HARA cells. HARA cells were highly dependent on MCL1 for survival, and MCL1-depleted cells were not able to grow, and even declined in number, upon docetaxel (DTX) exposure in vitro and in vivo. Similar in vitro experimental findings, including those in a 3D culture model, were also obtained using Detroit 562 pharyngeal SqCC cells. These findings suggested that combined treatment with MCL1 silencing plus DTX appears highly effective against airway-derived SqCC.

1 September 2022 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MTMakoto Tada
Makoto Tada
浩上浩文 上原
浩文 上原
TOTakeshi Ohyu
Takeshi Ohyu
AWAtsushi Watanabe
Atsushi Watanabe

1 August 2023 in General Thoracic and Cardiovascular Surgery Cases
Verified
Journal Article
Open access
PDF file
MTMakoto Tada
Makoto Tada
HUHirofumi Uehara
Hirofumi Uehara
TOTakeshi Ohyu
Takeshi Ohyu
AWAtsushi Watanabe
Atsushi Watanabe
Background: Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome is a rare chronic inflammatory disorder characterized by cystic skin disease, aseptic osteomyelitis, and hyperostosis. It is rarely associated with subcutaneous abscesses in the anterior chest wall. Herein, we describe a case of a sternal abscess due to SAPHO syndrome that was successfully treated with debridement. Case presentation: A 62-year-old female patient presented with a chief complaint of a mass in the right anterior chest region. Computed tomography showed the presence of an abscess around the sternum. Magnetic resonance imaging revealed inflammation of the spine. The patient also had a history of palmoplantar pustulosis, raising the suspicion of SAPHO syndrome; however, sternoclavicular joint infection could not be excluded. Abscess drainage and wall debridement were performed. However, reaccumulation of the abscess occurred early after surgery. Although culture tests of the abscess were negative, histopathological examination of the abscess wall revealed a tuberculoid granuloma. Owing to unsuccessful open wound management, debridement of the anterior thoracic skin and abscess wall and partial sternal resection were performed 2 months after the initial surgery. Negative-pressure wound therapy (NPWT) was applied for 4 weeks after surgery, followed by immunosuppressant administration. The patient underwent split-thickness skin grafting on postoperative day 65 and had no abscess recurrence at 18 months post-surgery. Conclusions: Abscesses in the sternal region caused by SAPHO syndrome can be difficult to differentiate from infectious arthritis. Therefore, drainage and debridement should be considered if infection cannot be excluded.

9 July 2018 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
YTYuki Takahashi
Yuki Takahashi
MMMasahiro Miyajima
Masahiro Miyajima
TMTaijiro Mishina
Taijiro Mishina
RMRyunosuke Maki
Ryunosuke Maki
MTMakoto Tada
Makoto Tada
AWAtsushi Watanabe
Atsushi Watanabe
Combined resection of a phrenic nerve is occasionally required in T3 primary lung carcinomas invading the phrenic nerve to completely remove a malignant tumour, resulting in diaphragmatic paralysis. We describe the first case of thoracoscopic lobectomy and diaphragmatic plication as a one-stage surgery for lung cancer invading the phrenic nerve. A 56-year-old woman with a T3N0M0 primary adenosquamous carcinoma in the left upper lobe presented with suspicious invasion to the anterior mediastinal fat tissue and left phrenic nerve and underwent left upper lobectomy, node dissection, and partial resection of the anterior mediastinal fat tissue with the left phrenic nerve. Furthermore, thoracoscopic diaphragmatic plication was performed as a concomitant procedure. The patient’s postoperative course was favourable, without any complications, and respiratory function was preserved for 1 year postoperatively. Thoracoscopic one-stage lobectomy and diaphragmatic plication for T3 lung cancer invading the phrenic nerve is effective for preservation of postoperative pulmonary function.

20 June 2023 in Thoracic Cancer
Verified
Journal Article
Open access
MTMakoto Tada
Makoto Tada
HUHirofumi Uehara
Hirofumi Uehara
TOTakeshi Ohyu
Takeshi Ohyu
AWAtsushi Watanabe
Atsushi Watanabe
We present the case of a patient who developed pulmonary artery occlusion following immune‐checkpoint inhibitor (ICI) therapy for non‐small cell lung cancer. A 69‐year‐old man with squamous cell carcinoma (yc‐T1cN0M0), initially diagnosed at c‐stage IVA (T3N1M1b), in the upper lobe of the left lung, was scheduled to undergo salvage lung resection after ICI therapy. However, he exhibited an occlusion of the lingular pulmonary artery near the clinically metastatic hilar lymph node. To avoid severe adhesions, the patient underwent successful wedge resection without dividing pulmonary vessels and was discharged without complications. Surgeons should be prepared for pulmonary artery changes following ICI therapy.